Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligand.
暂无分享,去创建一个
[1] J. Chauveau,et al. A new 5-hydroxy-indole derivative with preferential affinity for 5-HT1B binding sites. , 1991, European journal of pharmacology.
[2] B. Hoffman,et al. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes. , 1990, Molecular pharmacology.
[3] S. Peroutka,et al. 5‐Hydroxytryptamine receptor “families” , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] M. J. Sumner,et al. 5‐HT1D binding sites in porcine brain can be sub‐divided by GR43175 , 1989, British journal of pharmacology.
[5] M. Titeler,et al. Detection of a Novel Serotonin Receptor Subtype (5‐HT1E) in Human Brain: Interaction with a GTP‐Binding Protein , 1989, Journal of neurochemistry.
[6] S. Peroutka,et al. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] D. Hoyer,et al. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. , 1985, European journal of pharmacology.